Surgery & Jaw

White Patches in Mouth: Leukoplakia Causes and Risks

Leukoplakia is an oral potentially malignant disorder characterised by persistent white patches that cannot be scraped off. Learn about its aetiology, tobacco and areca nut risks, diagnostic biopsy procedures, dysplasia grading, surgical management, and crucial red flag symptoms.

11 min read Written and clinically reviewed by Dr. Amit Sharma, Oral & Maxillofacial SurgeonLast reviewed 3 September 2026

At a glance

  • The oral cavity is lined by a protective mucosal barrier composed of stratified squamous epithelium supported by underlying vascular connective tissue known as the lamina propria.
  • The development of oral leukoplakia is strongly linked to chronic exposure to chemical carcinogens and local irritants.
  • Clinically, oral leukoplakia presents across a spectrum of visual patterns and physical textures.
  • The diagnostic pathway for any suspicious leukoplakia white patch mouth presentation begins with a comprehensive extraoral and intraoral clinical examination.
  • The definitive biological assessment of oral leukoplakia relies on histopathological examination following biopsy, specifically looking for the presence and severity of epithelial dysplasia.

Understanding Oral Leukoplakia and Oral Anatomy

The oral cavity is lined by a protective mucosal barrier composed of stratified squamous epithelium supported by underlying vascular connective tissue known as the lamina propria. In healthy individuals, this lining is smooth, moist, and pliable, designed to withstand mechanical friction from mastication while resisting bacterial invasion. Oral leukoplakia is defined by the World Health Organization as a predominantly white plaque or patch of questionable risk having excluded other known diseases or disorders that carry no increased risk of cancer. It represents the most common oral potentially malignant disorder encountered in dental and maxillofacial clinical practice.

When oral tissues encounter chronic chemical or physical insults, the cellular machinery of the epithelium alters its normal maturation process. Keratinocytes—the primary cells of the surface epithelium—may produce an excessive quantity of keratin (hyperkeratosis) or retain cellular nuclei within the outer keratin layer (parakeratosis). This abnormal thickening of the superficial layer reflects light differently from normal translucent mucosa, manifesting clinically as a persistent leukoplakia white patch mouth lesion. These lesions can arise anywhere within the oral cavity, though high-risk anatomical sites include the ventrolateral borders of the tongue, the floor of the mouth, and the soft palate complex.

Aetiology and Risk Factors: Tobacco, Areca Nut, and Irritation

The development of oral leukoplakia is strongly linked to chronic exposure to chemical carcinogens and local irritants. Tobacco use in all forms remains the primary aetiological driver globally. Cigarette, cigar, and pipe combustion generates polycyclic aromatic hydrocarbons and nitrosamines that induce direct DNA damage within basal keratinocytes. In South Asian communities and global diaspora populations, smokeless tobacco formats such as khaini, zarda, and gutka, alongside the chewing of betel quid (paan) containing areca nut and slaked lime, present an exceptionally high risk. The alkaline slaked lime enhances the mucosal absorption of areca-derived alkaloids, which stimulate sustained cellular proliferation, mucosal damage, and genetic mutations.

Excessive alcohol consumption acts synergistically with tobacco use. Ethanol increases the mucosal permeability of the oral epithelium, allowing tobacco-derived and environmental carcinogens to penetrate deeper into the basal progenitor cell layers, while its primary metabolite, acetaldehyde, exerts direct mutagenic effects. Chronic mechanical irritation—such as trauma from a sharp fractured cuspal edge, an ill-fitting acrylic denture clasp, or habitual cheek biting (morsicatio buccarum)—can induce reactive frictional keratosis. While pure frictional keratosis resolves once the mechanical trigger is eliminated, persistent idiopathic lesions or those driven by chemical genotoxins carry biological unpredictability.

Clinical Presentation and Morphology

Clinically, oral leukoplakia presents across a spectrum of visual patterns and physical textures. A fundamental clinical hallmark is that the white patch cannot be wiped or scraped away with a dry gauze swab, distinguishing it immediately from transient surface accumulations such as pseudomembranous candidiasis or food debris. Lesions are broadly classified based on clinical appearance into homogeneous and non-homogeneous subtypes. Homogeneous leukoplakias are uniformly flat, thin, and smooth, occasionally displaying shallow fissures or a finely corrugated surface. They are typically asymptomatic and often discovered incidentally during routine dental examinations.

Non-homogeneous leukoplakias present with irregular topography and carry a substantially higher risk of harbouring epithelial dysplasia or malignant change. These include speckled leukoplakia (erythroleukoplakia), where white keratotic patches are interspersed with erythematous (red) atrophic areas; nodular leukoplakias, characterised by small, rounded mucosal elevations; and verrucous or exophytic forms, which display a raised, warty, or papillary architecture. Proliferative verrucous leukoplakia is a distinct, aggressive, multi-focal variant that tends to spread slowly across multiple mucosal sites, resists standard interventions, and demonstrates a high propensity for malignant transformation over time.

Diagnostic Pathway: Examination and Differential Diagnosis

The diagnostic pathway for any suspicious leukoplakia white patch mouth presentation begins with a comprehensive extraoral and intraoral clinical examination. The clinician systematically inspects and palpates the oral soft tissues, evaluating the precise margins, texture, induration (firmness), and anatomical extent of the lesion, alongside manual palpation of the cervical lymph node chains. Dental radiographs or cone-beam computed tomography (CBCT) are not used to diagnose mucosal white lesions directly, but they are essential when lesions approximate the alveolar ridge to exclude underlying osseous pathology, cortical erosion, or dental root involvement.

Differential diagnosis requires distinguishing leukoplakia from other oral white lesions. These include oral lichen planus (which typically presents with bilateral, symmetrical reticular white striations known as Wickham's striae), oral candidiasis, white sponge naevus, oral submucous fibrosis (characterised by fibrous bands, blanching, and restricted mouth opening commonly seen in areca nut users), and frictional keratosis. If a mechanical source of friction is identified, the offending factor is eliminated, and the lesion is reviewed after two to four weeks. If the white patch fails to resolve completely following habit cessation or source removal, an incisional diagnostic tissue biopsy is mandatory.

Classification and Grading of Epithelial Dysplasia

The definitive biological assessment of oral leukoplakia relies on histopathological examination following biopsy, specifically looking for the presence and severity of epithelial dysplasia. Dysplasia represents a constellation of cellular atypia and architectural tissue disturbances within the epithelium. Cellular abnormalities include nuclear pleomorphism (variation in nuclear size and shape), hyperchromatism (darkly staining nuclei), increased nuclear-to-cytoplasmic ratios, and atypical mitotic figures located above the basal layer. Architectural disruptions include loss of normal cellular stratification, basilar hyperplasia, and premature single-cell keratinisation (dyskeratosis) within the deeper strata.

The World Health Organization classifies epithelial dysplasia into three distinct tiers: mild, moderate, and severe. Mild dysplasia is confined to architectural and cytological disturbances within the lower third of the epithelial thickness. Moderate dysplasia extends the structural atypia into the middle third, while severe dysplasia exhibits pronounced cellular abnormalities occupying more than two-thirds of the epithelium without breaching the basement membrane. Carcinoma in situ represents full-thickness architectural atypia. The presence and escalating grade of dysplasia correlate directly with an increased statistical probability of future progression to invasive oral squamous cell carcinoma.

Surgical and Non-Surgical Management Options

Management strategies are tailored based on the clinical morphology, anatomical site, lesion size, and the presence or grade of histological dysplasia. The primary initial intervention for all patients is the absolute cessation of causative habits, including all forms of smoking, smokeless tobacco, areca nut consumption, and alcohol reduction. While systemic medical therapies—such as topical retinoids, carotenoids, and anti-inflammatory agents—have been investigated, consensus reviews indicate they do not provide reliable long-term prevention of malignant transformation and frequently carry systemic side effects upon cessation, limiting their use as primary treatment.

For lesions exhibiting moderate to severe dysplasia, or those displaying high-risk non-homogeneous features, complete surgical excision represents the primary standard of care. Surgical modalities include cold-steel scalpel excision, carbon dioxide (CO2) laser excision or ablation, and cryosurgery. Scalpel excision provides an intact, orientable specimen with readable margins for microscopic confirmation. Laser ablation vaporises tissue with excellent intraoperative haemostasis and minimal post-treatment scarring, but precludes complete margin assessment. Despite surgical removal, clinical recurrence can occur due to 'field cancerisation', wherein surrounding macroscopically normal mucosa harbours submicroscopic genetic alterations.

What to Expect During the Clinical and Biopsy Appointment

Undergoing an oral biopsy is an established, minor surgical outpatient procedure designed to secure an accurate diagnosis with minimal discomfort. Prior to the procedure, the surgeon reviews medical history, current medications—particularly anticoagulants or antiplatelet therapies—and confirms written informed consent. The oral cavity is illuminated, and the surgeon selects an appropriate representative site, focusing on non-homogeneous, red, or indurated areas rather than purely flat, thick white zones, to avoid missing focal dysplastic change.

The surgical site is anaesthetised using a local anaesthetic injection, similar to routine dental work, numbing the mucosal tissues within minutes. Using a scalpel or a sterile punch biopsy instrument, the clinician removes a small, wedge-shaped tissue sample (typically 3 to 6 millimetres) encompassing both the lesion and a small border of adjacent normal tissue, extending into the underlying lamina propria. Haemostasis is achieved using direct pressure or electrocautery, and the wound is typically closed with one or two small resorbable sutures that dissolve naturally over one to two weeks.

Recovery, Postoperative Aftercare, and Healing

Postoperative recovery following an oral mucosal biopsy or superficial surgical excision is generally straightforward. In the first 24 to 48 hours, patients may experience mild local discomfort, minor swelling, and slight blood-tinged saliva, which is managed effectively with standard over-the-counter analgesics such as paracetamol or ibuprofen. Patients are advised to adhere to a soft, cool diet, avoid hot, spicy, acidic, or crunchy foods, and refrain from smoking and alcohol, as both substances significantly delay mucosal re-epithelialisation and increase the risk of secondary infection.

Maintaining gentle oral hygiene is critical. Patients should continue brushing their remaining teeth normally while avoiding direct trauma to the surgical site, supplemented after the first 24 hours by gentle warm saline mouth rinses or chlorhexidine gluconate rinses as prescribed. Normal mucosal healing proceeds via granulation tissue formation; it is completely normal for a yellowish-white fibrinous slough to cover the wound bed during the first week. True complications—such as uncontrolled continuous bleeding, severe throbbing pain, foul-smelling purulent discharge, or spreading facial swelling—are uncommon and require prompt clinical review.

Long-Term Surveillance, Complications, and Recurrence

A critical principle in the clinical management of oral leukoplakia is that surgical excision does not guarantee permanent cure or completely eliminate future cancer risk. Because the entire upper aerodigestive tract may have been exposed to widespread historical carcinogens—a process termed field cancerisation—new lesions can emerge in previously unaffected mucosal sites, and excised lesions may recur at surgical margins. Consequently, structured, lifelong clinical surveillance is an indispensable component of care for every patient diagnosed with an oral potentially malignant disorder.

Follow-up schedules are determined by individual risk stratification. Patients with homogeneous lesions showing no or mild dysplasia are generally reviewed every six to twelve months. Conversely, patients with non-homogeneous morphology, high-grade dysplasia, lesions located on the floor of the mouth or lateral tongue, or a diagnosis of proliferative verrucous leukoplakia require stringent three- to six-month reviews. Each surveillance appointment involves high-definition visual inspection, photographic documentation, and bilateral palpation of the oral mucosa and neck to detect early dysplastic recurrence or malignant conversion.

Red Flag Symptoms Requiring Urgent Clinical Evaluation

While many white patches remain stable over extended periods, certain clinical alterations indicate immediate disease progression or underlying malignancy requiring rapid assessment. Patients and clinicians must maintain high vigilance for warning signs that necessitate urgent referral to an oral and maxillofacial surgery or oral medicine department. National referral pathways, such as the two-week wait suspected cancer pathway in the UK National Health Service, ensure timely multidisciplinary evaluation for concerning clinical features.

Key red flags include any oral leukoplakia white patch mouth lesion that develops persistent deep ulceration, rapid enlargement over a period of weeks, or noticeable induration (firm, hard texture upon palpation). Other critical indicators include spontaneous bleeding without mechanical trauma, the development of red (erythroplakic) velvety patches, persistent unexplained oral pain, sensory changes such as numbness or tingling of the lip or tongue, difficulty or pain upon swallowing (dysphagia), loose teeth without periodontal explanation, or the emergence of a firm, painless, progressively enlarging lump in the neck.

Evidence and further reading

International consensus guidelines published by the World Health Organization (WHO) Collaborating Centre for Oral Cancer continuously refine the nomenclature, diagnostic criteria, and classification frameworks for oral potentially malignant disorders. Broad clinical consensus emphasises that histological grading of epithelial dysplasia remains the single most reliable prognostic indicator for malignant transformation risk, though non-dysplastic lesions still retain a baseline risk of conversion that warrants structured long-term observation.

Clinical guidance from the National Institute for Health and Care Excellence (NICE), the British Association of Oral and Maxillofacial Surgeons (BAOMS), and the American Dental Association (ADA) underscores the primacy of scalpel biopsy as the gold standard for definitive tissue diagnosis. Cochrane systematic reviews examining interventions for oral leukoplakia conclude that while surgical excision and cessation of risk habits remain core management pillars, there is an ongoing need for high-quality, long-term randomised trials to evaluate the efficacy of targeted molecular and surgical modalities in preventing malignant transformation.

Questions patients ask us

Can oral leukoplakia turn into mouth cancer?
Yes, oral leukoplakia is classified as a potentially malignant disorder. While many lesions remain benign throughout a patient's life, a proportion can transform into oral squamous cell carcinoma over time. The risk of transformation increases substantially if the patch displays non-homogeneous features (such as red speckled areas or warty textures), is located under the tongue or on its side, or reveals moderate to severe epithelial dysplasia on tissue biopsy.
Will a white patch disappear if I stop smoking or using paan?
In some cases, especially where the white patch represents reactive hyperkeratosis driven purely by tobacco smoke or areca nut use, completely stopping the habit can lead to partial regression or complete resolution of the lesion over several weeks to months. However, habit cessation does not guarantee resolution or reverse deep genetic damage. Any patch that persists after habit cessation must be formally evaluated with a biopsy.
Is an oral biopsy for leukoplakia painful?
An oral biopsy is performed under local anaesthesia, meaning the area is completely numbed and you will not feel pain during the procedure. You may feel slight pressure or movement. Once the anaesthetic wears off after a few hours, mild soreness or tenderness is normal for two to three days, which is generally well controlled with standard over-the-counter pain relievers such as paracetamol.
How does leukoplakia differ from oral thrush (candidiasis)?
The key clinical difference is adherence. Oral thrush (candidiasis) produces soft, curd-like white plaques that can be wiped or scraped off with gauze, often leaving a red, tender, or bleeding base. Oral leukoplakia is firmly attached to the mucosal lining and cannot be wiped away. Thrush responds rapidly to antifungal medications, whereas leukoplakia does not resolve with antifungal therapy.
What does a high dysplasia grade mean for my treatment?
A high dysplasia grade (severe dysplasia or carcinoma in situ) means that under the microscope, the cells show marked structural and genetic abnormalities, indicating a significant risk of developing into cancer. When severe dysplasia is found, oral surgeons typically recommend complete surgical excision of the lesion, combined with closer, more frequent long-term surveillance to monitor for recurrence or new lesions.
Can I use mouthwash to treat a leukoplakia white patch in my mouth?
No, commercial mouthwashes cannot cure or remove oral leukoplakia. In fact, using mouthwashes with high alcohol content can cause additional chemical irritation to an already vulnerable oral mucosal lining. While antibacterial or soothing mouth rinses may be recommended by your surgeon after a biopsy to aid wound healing, they do not treat the underlying cellular changes of leukoplakia.
Why do I need long-term follow-up if my white patch was removed?
Long-term follow-up is necessary because oral leukoplakia can recur at the surgical site, and new patches can develop elsewhere in the mouth. This occurs due to 'field cancerisation', where chronic exposure to tobacco, areca nut, or other irritants has created invisible, widespread genetic alterations across the oral lining. Regular check-ups ensure any recurrence or new lesion is detected and treated early.
What are the earliest signs that a white patch might be worsening?
Early warning signs of disease progression include the development of red or velvety patches within or around the white area (speckling), the surface becoming rough, nodular, or ulcerated, the lesion feeling noticeably hard or firm (induration), spontaneous bleeding, or persistent local discomfort. If you notice any of these changes, arrange a prompt review with your oral specialist.

When to see us

Get examined without waiting if any of the following applies to you:

  • Swelling that spreads, restricts mouth opening or affects swallowing or breathing
  • Numbness, altered sensation, or bleeding that will not stop after surgery
  • Jaw locking, an ulcer or lump lasting more than two weeks, or a white or red patch that does not heal
Treated at this hospital

Get a written plan and cost before you commit

If this is what you are dealing with, the next step is a consultation with radiographs — surgery & jaw cases are seen by the specialist who handles that field. You get a written plan and staged cost before anything begins.

reception@dramitsharmahospital.com
Please note

This article is general education and does not replace an in-person examination, radiographs or a diagnosis by a qualified dentist.

Related in Surgery & Jaw

9 min read

Wisdom Tooth Problems: Symptoms, Impaction and When Removal Is Needed

Why wisdom teeth cause pain and swelling, what impaction means, and how to decide between monitoring and surgical removal.

9 min read

Wisdom Teeth and Impactions

When third molars need removal, what impaction means, and what recovery realistically looks like.

10 min read

Jaw Surgery, TMJ Disorders and Facial Trauma

Corrective jaw surgery, temporomandibular joint pain and management of facial injuries by a maxillofacial team.

11 min read

Laser Periodontal Therapy Procedure Benefits and Recovery

Laser periodontal therapy, including the LANAP protocol, uses targeted wavelength lasers to treat moderate-to-severe periodontitis. This guide covers biological mechanisms, procedural stages, recovery guidelines, evidence-based outcomes, and long-term periodontal maintenance strategies.

11 min read

Connective Tissue Graft Surgery for Receding Gums

Connective tissue gum graft surgery repairs severe gingival recession by transplanting donor tissue beneath receded gums. This evidence-based guide explains surgical techniques, anatomical principles, recovery timelines, clinical classifications, risks, and postoperative maintenance for optimal root coverage.

11 min read

Free Gingival Graft Procedure to Thicken Gums

A free gingival graft is a proven periodontal surgical procedure designed to augment thin or deficient attached gum tissue. This comprehensive guide covers anatomical indications, surgical steps, donor and recipient healing phases, complications, and evidence-based post-operative recovery protocols.